30.12.2012 Views

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

MANUFACTURING ASPECTS 69<br />

stations supplied with unidirectional airfl ow (UDAF) <strong>and</strong> with a lower pressure<br />

compared to the aseptic laboratory. The laboratory itself may then have positive<br />

pressure in relation to the surrounding premises.<br />

Waste management is an important aspect when planning a radiopharmaceutical<br />

manufacturing site. The key factor is to reduce the amount of radioactive waste to<br />

a minimum. There should be a system for dividing the waste according to physical<br />

half - life <strong>and</strong> radiotoxicity, both for solid <strong>and</strong> liquid waste. As an example, waste<br />

containing α emitters is normally kept separately, when possible. National legislation<br />

will vary considerably <strong>and</strong> infl uence the requirement that must be set for h<strong>and</strong>ling<br />

of radioactive waste material.<br />

1.3.3.2 Design of <strong>Production</strong> Processes<br />

The design of a radiopharmaceutical production process depends very much upon<br />

the kind of radiopharmaceutical to be made. Although most radiopharmaceuticals<br />

are intended for parenteral use, also oral radiopharmaceuticals in different forms<br />

are widely used. One must emphasize different factors when planning for production<br />

of parenteral radiopharmaceuticals compared to oral radiopharmaceuticals.<br />

Still, a common factor is the involvement of radioactive materials, <strong>and</strong> the radiation<br />

protection of the personnel must always be an integral part of the design.<br />

The production of a radiopharmaceutical will normally take place within a contained<br />

box unit, consisting of either plastic walls or a combination of plastic <strong>and</strong><br />

stainless steel. The latter is more optimal for clean - room work. The box units may<br />

be shielded by lead, either as large lead panels or as lead brick walls (see Figure 1 ).<br />

Depending on the kind of radionuclides used <strong>and</strong> the amount of radioactivity<br />

h<strong>and</strong>led in the box, the walls are typically 5 – 15 cm in thickness. Shielded production<br />

units like these are often called “ hotcells. ”<br />

When the box is used for productions of radiopharmaceuticals incorporating α -<br />

or β - emitting radionuclides, closed box units without any lead coating may be suffi -<br />

cient. When h<strong>and</strong>ling radionuclides with mixed emitting properties, a possibility is<br />

to concentrate the shielding to critical parts of the process. This can be done by use<br />

of local shielding inside the production unit. However, for aseptic production, one<br />

must keep in mind a potential disturbance of the airfl ow inside the box.<br />

FIGURE 1 Shielding of box units (hot cells) with lead bricks. ( Photo courtesy of Institute<br />

for Energy Technology .)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!